GEHC Launches ReadyFix Fleet Management to Boost ECG Efficiency

GE HealthCare Technologies Inc. GEHC recently announced the U.S. launch of ReadyFix, a remote fleet management solution aimed at improving medical device uptime and operational efficiency across healthcare systems. The solution integrates with the company’s MAC VU360 resting ECG workstations — devices engineered to provide high-quality ECG measurements and real-time data access for remote device diagnosis, repair and proactive maintenance to support uninterrupted cardiac care delivery. 

Per management, the growing adoption of complex, connected medical devices is accelerating the need for efficient fleet management solutions. ReadyFix, initially launched for the MAC VU360 ECG platform with plans for broader device compatibility, is designed to simplify workstation maintenance and operations, allowing care teams to remain focused on timely cardiac patient care.

Likely Trend of GEHC Stock Following the News

Following the announcement, shares of GEHC lost 1.9% at yesterday’s closing. Over the past six months, shares of the company have gained 8.3% against the industry’s 11.3% decline. However, the S&P 500 has risen 11% during the same time frame.

In the long run, the launch of ReadyFix is expected to provide GEHC with a focused entry point into cardiac diagnostics while creating a scalable platform for future expansion. The solution enhances device uptime, enables proactive maintenance through real-time diagnostics and supports standardized configurations, improving operational efficiency for healthcare providers. By addressing workforce shortages and device-management complexity, ReadyFix may drive higher customer adoption, recurring software-enabled service revenues and deeper integration of GE HealthCare systems across hospitals, reinforcing the company’s competitive positioning in patient monitoring and cardiac diagnostics.

GEHC currently has a market capitalization of $36.76 billion.

More on ReadyFix

ReadyFix extends GEHC’s DeviceReady remote fleet management portfolio by enabling biomedical teams to centrally manage device complexity through remote, department-level deployment of standardized clinical configurations, ensuring consistent workflows and patient protocols. The platform supports instant or scheduled software updates, along with remote access to diagnostics and log files for proactive maintenance, reducing device-related downtime. Its configuration management capabilities further allow post-installation device standardization and facilitate secure, reliable ECG data transmission, thereby improving operational efficiency and care consistency.

From a technology perspective, ReadyFix leverages real-time access to device diagnostic tools and log files, allowing biomedical engineering teams to proactively identify and resolve issues before they impact patient care. This capability is relevant as hospitals contend with increasing device density — often 10 to 15 connected devices per bed — requiring biomedical engineering teams to oversee thousands of assets, which increases maintenance complexity and repair workloads.

Reflecting this pressure, 56% of biomedical engineers report ‘heavy’ or ‘excessive’ workloads. Workforce constraints are expected to intensify, as the United States Bureau of Labor Statistics projects over 7,300 annual job openings for biomedical equipment technicians in the coming decade, while the education pipeline produces only about 400 graduates annually, widening the supply-demand gap. By improving visibility and control over ECG fleets, ReadyFix helps hospitals maintain high reliability standards despite constrained resources.

Tony Williams, Director of Biomedical Engineering at Baptist Hospital, notes that remote fleet management solutions deliver improved visibility, operational structure and real-time insights. These capabilities enable proactive equipment issue management and support high reliability standards for patient-care devices, while enhancing the effectiveness of biomedical engineering operations.

Industry Prospects Favoring the Market

Going by the data provided by Precedence Research, the fleet management market is valued at $32.29 billion in 2026 and is expected to witness a CAGR of 10% through 2035.

Factors like the expansion of connected medical devices, operational efficiency and cost optimization, workforce shortages and workload pressures, cybersecurity and regulatory compliance requirements and the shift toward value-based care and remote patient monitoring are driving the market’s growth.

Other News

GE HealthCare recently announced a collaboration with AI-focused prenatal screening company Diagnoly to integrate Diagnoly’s Fetoly real-time AI solution into its Voluson women’s health ultrasound systems. Fetoly enables standardized fetal ultrasound examinations aligned with ISUOG guidelines, offering AI-driven diagnostic support for fetal heart and brain assessments while automatically verifying exam completeness and quality in real time. The integration is expected to strengthen the Voluson portfolio by enhancing workflow efficiency, standardization and clinical decision support, thereby improving prenatal imaging quality and maternal-fetal care delivery.

GEHC has secured FDA 510(k) clearance and CE marking for Allia Moveo, enabling commercialization of its latest mobile C-arm interventional imaging platform in the United States and Europe. Introduced at RSNA 2025, the system expands the Allia portfolio and supports cardiovascular, vascular, non-vascular, surgical and interventional procedures. Featuring a compact, cable-free design, intuitive interface and AI-enabled guidance capabilities, Allia Moveo is designed to improve procedural workflow efficiency while addressing space constraints commonly present in interventional suites.

GE HealthCare Technologies Inc. Price

GE HealthCare Technologies Inc. price | GE HealthCare Technologies Inc. Quote

GEHC’s Zacks Rank & Key Picks

Currently, GEHC has a Zacks Rank #3 (Hold).

Some better-ranked stocks from the broader medical space are Intuitive Surgical ISRG, Veracyte VCYT and AtriCure ATRC.

Intuitive Surgical, sporting a Zacks Rank #1 (Strong Buy) at present, reported fourth-quarter 2025 adjusted earnings per share (EPS) of $2.53, beating the Zacks Consensus Estimate by 12.4%. Revenues of $2.87 billion surpassed the Zacks Consensus Estimate by 4.7%. You can see the complete list of today’s Zacks #1 Rank stocks here.

ISRG has an estimated long-term earnings growth rate of 15.7% compared with the industry’s 12.7% rise. The company beat earnings estimates in the trailing four quarters, the average surprise being 13.2%.

Veracyte, currently sporting a Zacks Rank #1, reported a third-quarter 2025 adjusted EPS of 51 cents, which surpassed the Zacks Consensus Estimate by 59.4%. Revenues of $131.8 million beat the Zacks Consensus Estimate by 5.5%.

VCYT has an estimated earnings recession rate of 3% for 2026 compared with the industry’s 17.4% rise. The company beat earnings estimates in the trailing four quarters, the average surprise being 45.1%.

AtriCure, currently carrying a Zacks Rank #2 (Buy), reported a third-quarter 2025 adjusted loss per share of 1 cent, narrower than the Zacks Consensus Estimate by 90.9%. Revenues of $134.3 million beat the Zacks Consensus Estimate by 2.1%.

ATRC has an estimated earnings growth rate of 91.7% for 2026 compared with the industry’s 16.3% rise. The company beat earnings estimates in the trailing four quarters, the average surprise being 67.1%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research